WXWeijia Xiang

Weijia Xiang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Weijia Xiang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Lanqi Shang

    Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People’s Republic of China

    2 shared publications
  • Mengting Lun

    Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People’s Republic of China

    2 shared publications
  • Songyan Qu

    Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People’s Republic of China

    2 shared publications
  • Ya Xu

    Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People’s Republic of China

    2 shared publications
  • Yinhong Song

    Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People’s Republic of China

    2 shared publications
  • Yizhen Yin

    Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People’s Republic of China

    2 shared publications

Latest Publications

  • Open Access

    A Comprehensive Review of Hedyotis Diffusa Willd–Scutellaria Barbata D. Don Herb Pair in Anti- Hepatocellular Carcinoma Effects and Their Combinatorial Effects and Mechanisms

    by Ya Xu, Weijia Xiang, Wanyi Zhu, Lanqi Shang, Mengting Lun, Songyan Qu, Yizhen Yin, Changrong Chen, Honggang Yuan, Yinhong Song

    Hepatocellular carcinoma (HCC) is among the most prevalent malignancies of the digestive system, with a global rising incidence. Hedyotis diffusa Willd and Scutellaria barbata D. Don are classic herb pair in traditional Chinese medicine (TCM) of clearing heat and detoxifying, and is widely applied in the treatment of HCC. Although existing research has confirmed their efficacy against HCC through modulation of apoptosis, proliferation, angiogenesis, and immune responses, it is noteworthy that the combined or newly generated components after the compatibility of the two herbs exhibit even more pronounced therapeutic effects. In order to verify the pharmacological activity of the combination of Hedyotis diffusa Willd and Scutellaria barbata D. Don, it is necessary to try more in vitro and in vivo models. This review synthesizes current evidence on their TCM compatibility principles, pharmacological actions, and related signaling pathways of this herb pair, providing a rigorous theoretical foundation to guide rational clinical application and further translational research on the compatibility mechanism of the Hedyotis diffusa Willd–Scutellaria barbata D. Don herb pair in the treatment of HCC.


  • Open Access

    Recent Advances in Host Immune Mechanisms Against Listeria monocytogenes Infection

    by Lanqi Shang, Weijia Xiang, Mengting Lun, Songyan Qu, Yizhen Yin, Ya Xu, Yongqin Zhou, Ping Zhu, Yinhong Song

    Listeria monocytogenes (Lm) is a foodborne Gram-positive pathogenic bacterium that primarily causes clinical manifestations such as sepsis, meningitis, and monocytosis. The main susceptible populations include newborns, pregnant women, adults over 40 years old, and immunocompromised individuals. Currently, antibiotic therapy remains the primary clinical treatment, but in recent years the issue of antibiotic resistance has become increasingly prominent. This review summarizes recent advances in host immune mechanisms against Lm infection, focusing on: (1) the defensive roles of host barrier systems (intestinal, blood-brain, and placental barriers); (2) innate immune responses, including pathogen recognition via TLRs/NLRs signaling pathways, macrophage phagocytosis, and NK cell immune surveillance; and (3) adaptive immunity, particularly CD4+/CD8+ T cell-mediated specific immune responses and the long-term protective effects of memory T cells. By systematically elucidating the molecular mechanisms of these immune processes, this review aims to provide novel therapeutic strategies through enhancement of host immune functions for clinical management of Lm infection.